Compare Neurocrine Biosciences Inc (NBIX) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs United Airlines Holdings Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while United Airlines Holdings Inc trades at $118.05 (market cap $38.15B). The key difference: United Airlines Holdings Inc is far larger — about 2.2× Neurocrine Biosciences Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | UAL | |
|---|---|---|
Market Cap | $17.40B | $38.15B |
Sector | Health | Industrials |
52-Week High | $180.55 | $136.11 |
52-Week Low | $123.10 | $84.57 |
Enterprise Value | $16.49B | $55.18B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
